Today: 30 April 2026
Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher
23 January 2026
1 min read

Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Mumbai, Jan 23, 2026, 16:14 IST

Atul Ltd shares finished roughly 1% up on Friday following a strong quarterly profit report from the Indian speciality chemicals company. The stock closed at 5,833.25 rupees, marking a 1.03% gain.

As India’s December-quarter earnings season unfolds, investors are sorting out signal from noise. In chemicals, even a slight move in costs or pricing quickly impacts margins.

Labour costs have added a new wrinkle. Firms are now wrestling with how India’s new labour codes affect the accounting of certain employee benefit expenses.

Indian stocks closed lower, the Nifty 50 slipping 0.95% to 25,048.65.

Atul reported a consolidated net profit of 163.54 crore rupees for the October-December quarter, the third in its 2025-26 fiscal year ending March. Revenue for the period reached 1,573.62 crore, marking an 11% rise from a year ago, while profit jumped nearly 40%. However, profit slipped compared to the previous quarter despite a slight increase in sales. Revenue from life science chemicals fell marginally, whereas performance and other chemicals saw growth. The company also noted a 36.61 crore rupee provision in its standalone accounts related to the new labour codes.

Costs kept climbing. Operating expenses increased 2.9% from the previous quarter, reaching 1,410.06 crore rupees. Employee benefit expenses surged to 166.73 crore, which included a 41.35 crore rupee provision tied to labour code changes. For the nine months ending Dec. 31, revenue grew 11.4% to 4,603.47 crore, while profit rose to 478.27 crore, the report noted.

Atul reported EBITDA of roughly 248 crore rupees, with its margin slipping slightly to 15.7% from 15.8% the previous year, ET Now said.

Sunil Lalbhai serves as the chairman of the company. Its publicly traded competitors in India’s speciality chemicals sector include Navin Fluorine International, Deepak Nitrite, and Vinati Organics, based on market data services.

The key variable remains whether labour-code related provisioning and employee expenses stay high — and if demand remains strong enough for producers to maintain price hikes. Should costs remain elevated while pricing falters, earnings could drop sharply, even if sales stay steady.

Stock Market Today

  • Park Medi World Stock Dips After Strong 56% YTD Gain Amid Expansion Plans
    April 30, 2026, 3:57 AM EDT. Park Medi World shares fell 0.52% to ₹234 on the NSE after early gains on April 30, despite a robust 56% year-to-date return. The healthcare company's stock initially rallied following a 'buy' rating from Choice Institutional Equities, which set a ₹320 target price, citing expected compound annual growth rates (CAGR) of 26.3% revenue, 27.1% EBITDA, and 34.6% PAT through 2026-2029. The broker highlighted growth drivers including capacity expansion, improved case mix, and payor mix optimization. Park recently opened a multispecialty hospital in Panchkula, expanding its Northern India presence alongside ongoing developments in Mohali. The group operates 16 hospitals with nearly 4,000 beds, targeting 5,460 beds by 2028. The stock's resilience contrasts broader market weakness, gaining 2.39% weekly and 23.28% monthly, reflecting investor confidence in its expansion and operational strategy.

Latest article

Australia Stock Market Today: ASX 200 Falls Again as Oil Shock, Woolworths Warning Hit Shares

Australia Stock Market Today: ASX 200 Falls Again as Oil Shock, Woolworths Warning Hit Shares

30 April 2026
Sydney, April 30, 2026, 17:48 (AEST) Australian shares fell for an eighth straight session on Thursday, with the S&P/ASX 200 closing 0.24% lower at 8,665.8 as selling in miners and consumer staples offset gains in energy and banks. The benchmark had been down 0.5% in early trade. The timing made the move matter more than the size. The fall came a day after the Australian Bureau of Statistics said the Consumer Price Index, a measure of household price changes, rose 4.6% in the year to March, up from 3.7% in February; trimmed mean inflation, a gauge that strips out the
Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap
Previous Story

Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap

Nvidia stock climbs as China order signal lifts AI chips; Intel slide keeps traders wary
Next Story

Nvidia stock climbs as China order signal lifts AI chips; Intel slide keeps traders wary

Go toTop